PiaSky REMS 2024 340 mg/2 mL Injection For Subcutaneous Use User Guide
Learn about REMS 2024 340 mg/2 mL Injection for Subcutaneous Use with PIASKY. Understand the serious risks associated with this prescription medicine for treating paroxysmal nocturnal hemoglobinuria (PNH) in adults and children 13 years of age and older. Familiarize yourself with the PIASKY REMS program and essential instructions for safe usage. If you experience symptoms of meningococcal infection while on PIASKY, seek immediate medical attention.